<p>The numbers of the six macaques injected (2 macaques/gp in three different studies) are indicated and the times of the bleeds are color coded.</p
(A) Schematic of the study procedures (B-C) The concentrations of VRC01 (B) and Rh-α4β7 (C) were mea...
<p>mDC counts are illustrated as a percentage of the baseline mDC counts recorded prior to SIVagmSab...
<p>The three vaccinated macaques that did not show any evidence of infection had high titer of anti-...
<p>Data are an average of two macaques. Each pharmacokinetics study was repeated once or twice. (A) ...
<p>(A) unimmunized macaques, (B) SHIV-immunized macaques and (C) progesterone-treated, SHIV-immunize...
<p>Binding antibody titers to SIV<sub>mac239</sub> gp120 and gp140 over the course of immunization a...
<p>(A) Plasma samples from the 11 macaques injected (color coded) were collected 2–3 weeks following...
<p>Plasma samples from macaques confirmed positive or negative for RhCMV (54 RhCMV seropositive, 35 ...
<p>The data are shown as individual animal responses (circles) or as the mean antibody units for eac...
<p>Antibody levels are reflected by Median fluorescence intensity (MFI) value. Each symbol represent...
(A) Macaques (n = 3 per group) were infected with A/Yokohama/91/2007 (H1N1) and 56 days later vaccin...
<p>Panel A: Plasma viral loads. Panel B: CD4 counts. The sequential treatments are represented by th...
Two macaques #T769 (blue), T770 (red) received two 5mg/kg injections SC six weeks apart (arrows). An...
<p>Virus infection status was determined by PCR for SIV<i>gag</i> proviral DNA and virus isolation (...
Each color represents measurements from one of seven macaques (corresponding identification codes in...
(A) Schematic of the study procedures (B-C) The concentrations of VRC01 (B) and Rh-α4β7 (C) were mea...
<p>mDC counts are illustrated as a percentage of the baseline mDC counts recorded prior to SIVagmSab...
<p>The three vaccinated macaques that did not show any evidence of infection had high titer of anti-...
<p>Data are an average of two macaques. Each pharmacokinetics study was repeated once or twice. (A) ...
<p>(A) unimmunized macaques, (B) SHIV-immunized macaques and (C) progesterone-treated, SHIV-immunize...
<p>Binding antibody titers to SIV<sub>mac239</sub> gp120 and gp140 over the course of immunization a...
<p>(A) Plasma samples from the 11 macaques injected (color coded) were collected 2–3 weeks following...
<p>Plasma samples from macaques confirmed positive or negative for RhCMV (54 RhCMV seropositive, 35 ...
<p>The data are shown as individual animal responses (circles) or as the mean antibody units for eac...
<p>Antibody levels are reflected by Median fluorescence intensity (MFI) value. Each symbol represent...
(A) Macaques (n = 3 per group) were infected with A/Yokohama/91/2007 (H1N1) and 56 days later vaccin...
<p>Panel A: Plasma viral loads. Panel B: CD4 counts. The sequential treatments are represented by th...
Two macaques #T769 (blue), T770 (red) received two 5mg/kg injections SC six weeks apart (arrows). An...
<p>Virus infection status was determined by PCR for SIV<i>gag</i> proviral DNA and virus isolation (...
Each color represents measurements from one of seven macaques (corresponding identification codes in...
(A) Schematic of the study procedures (B-C) The concentrations of VRC01 (B) and Rh-α4β7 (C) were mea...
<p>mDC counts are illustrated as a percentage of the baseline mDC counts recorded prior to SIVagmSab...
<p>The three vaccinated macaques that did not show any evidence of infection had high titer of anti-...